MetaCap

Attovia Therapeutics (ATTO) vs Solid Biosciences (SLDB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Solid Biosciences is the larger company by market cap ($697.6 million vs $690.3 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ATTO-31.05%SLDB-28.41%
+22%-9%-40%
Aug 5, 20261 yearNov 20, 2026
ATTO-25.14%SLDB-25.51%
+30%-4%-37%
Aug 3, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ATTO versus SLDB key metrics
MetricATTOSLDB
Share price$15.10$6.25
Market cap$690.26M$697.57M
1-day change-3.08%-2.95%
YTD return—+10.82%
1-year return—+32.98%
5-year return—-77.78%
EPS (TTM)$-5.53$-1.76
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)—$-174.32M
52-week high$28.00$11.45
52-week low$12.94$4.65
Distance from 52-week high-46.07%-45.41%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+186.09%+199.36%
Average volume337.27K1.30M
Shares outstanding45.71M111.61M
Employees50121
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Attovia Therapeutics

ATTO stock →

Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 50 employees

About Solid Biosciences

SLDB stock →

Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 121 employees

ATTO vs SLDB FAQ

Which is bigger, Attovia Therapeutics or Solid Biosciences?

Solid Biosciences (SLDB) is larger, with a market capitalization of $697.57M compared with $690.26M for Attovia Therapeutics (ATTO).

Are Attovia Therapeutics and Solid Biosciences in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons